Anders Hultman

Track

Insider profile

Currently holds positions in AroCell AB (publ) and Calliditas Therapeutics AB

Positions

Position Company Period
Chief Financial Officer AroCell AB (publ) Dec. 1, 2018 -
Chief Financial Officer Calliditas Therapeutics AB None -
Anders Hultman's trades of AroCell AB (publ)'s stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2022-05-11 2022-05-10
B Purchase
14,943
137.32
SEK4,636,626 		14,943 137.32 SEK4,636,626
2022-05-09 2022-05-09
B Purchase
6,415
37.17
SEK4,377,025 		6,415 37.17 SEK4,377,025
2022-05-03 2022-05-03
B Purchase
89,134
444.26
SEK4,395,177 		89,134 444.26 SEK4,395,177
2021-01-19 2021-01-19
B Purchase
20,000
2.67
SEK53,312 		20,000 2.67 SEK53,312
2019-12-06 2019-12-04
B Purchase
60,000
1.50
SEK90,000 		60,000 1.50 SEK90,000
2019-11-27 2019-11-26
B Purchase
60,000
0.01
SEK522 		60,000 0.01 SEK522
2019-11-26 2019-11-26
B Purchase
60,000
0.01
SEK522 		60,000 0.01 SEK522
2018-12-05 2018-12-05
B Purchase
7,831
2.24
SEK17,541 		7,831 2.24 SEK17,541
2018-11-28 2018-11-28
B Purchase
10,000
2.51
SEK25,100 		10,000 2.51 SEK25,100
2018-11-21 2018-11-21
B Purchase
10,000
2.50
SEK25,000 		10,000 2.50 SEK25,000
2018-11-15 2018-11-15
B Purchase
7,400
2.73
SEK20,202 		7,400 2.73 SEK20,202
2018-11-14 2018-11-14
B Purchase
20,000
3.10
SEK62,000 		20,000 3.10 SEK62,000